Objectives: Gastrointestinal (GI) inflammation and GI integrity deficits are common comorbidities of neuropsychiatric disorders. Ongoing research suggests that these aberrations may be contributing to heightened immune signals that have the potential to disrupt neuronal homeostasis and exacerbate behavioural deficits. The current study aimed to determine whether the well-characterized animal model of neuropsychopathology, the maternal immune activation (MIA) model, produced GI inflammation and integrity disruptions in association with anxiety-like behaviour. Methods: Pregnant Wistar rats were exposed to the viral mimetic polyriboinosinic:polyribocytidilic acid (polyI:C) on gestational days (GD) 10 and 19. Evidence of ANS activation, GI inflammation, and GI barrier integrity was assessed in both neonatal (postnatal day, P7) and adult (P84) offspring. Anxiety-like behaviour was assessed at P100. Results: Neonatal MIA offspring exhibited an altered intestinal inflammatory profile and evidence of an increase in lymphoid aggregates. MIA neonates also displayed disruptions to GI barrier tight junction protein mRNA. In addition, adult MIA offspring exhibited an increase in anxiety-like behaviours. Conclusion: These results indicate that the MIA rat model, which is well documented to produce behavioural, neurochemical, and neuroanatomical abnormalities, also produces GI inflammation and integrity disruptions. We suggest that this model may be a useful tool to elucidate biological pathways associated with neuropsychiatric disorders.

1.
Craske
MG
,
Stein
MB
.
Anxiety
.
Lancet
.
2016
Dec
;
388
(
10063
):
3048
59
.
[PubMed]
0140-6736
2.
World Health Organisation
:
Investing in treatment for depression and anxiety leads to fourfold return
.
2016
;:1–3.
3.
Senate Select Committee on Health
: Fourth interim report - Mental health: a consensus for action. Commonwealth of Australia,
2015
.
4.
Nowakowski
J
,
Chrobak
AA
,
Dudek
D
.
Psychiatric illnesses in inflammatory bowel diseases - psychiatric comorbidity and biological underpinnings
.
Psychiatr Pol
.
2016
Dec
;
50
(
6
):
1157
66
.
[PubMed]
0033-2674
5.
Abautret-Daly
A
,
Dempsey
E
,
Parra-Blanco
A
,
Medina
C
,
Harkin
A
.
Gut-brain actions underlying comorbid anxiety and depression associated with inflammatory bowel disease
.
Acta Neuropsychiatr
.
2017
Mar
;
•••
:
1
22
.
[PubMed]
0924-2708
6.
Lydiard
RB
,
Fossey
MD
,
Marsh
W
,
Ballenger
JC
.
Prevalence of psychiatric disorders in patients with irritable bowel syndrome
.
Psychosomatics
.
1993
May-Jun
;
34
(
3
):
229
34
.
[PubMed]
0033-3182
7.
Walker
EA
,
Roy-Byrne
PP
,
Katon
WJ
,
Li
L
,
Amos
D
,
Jiranek
G
.
Psychiatric illness and irritable bowel syndrome: a comparison with inflammatory bowel disease
.
Am J Psychiatry
.
1990
Dec
;
147
(
12
):
1656
61
.
[PubMed]
0002-953X
8.
Kumano
H
,
Kaiya
H
,
Yoshiuchi
K
,
Yamanaka
G
,
Sasaki
T
,
Kuboki
T
.
Comorbidity of irritable bowel syndrome, panic disorder, and agoraphobia in a Japanese representative sample
.
Am J Gastroenterol
.
2004
Feb
;
99
(
2
):
370
6
.
[PubMed]
0002-9270
9.
Kawoos
Y
,
Wani
ZA
,
Kadla
SA
,
Shah
IA
,
Hussain
A
,
Dar
MM
, et al.
Psychiatric Co-morbidity in Patients With Irritable Bowel Syndrome at a Tertiary Care Center in Northern India
.
J Neurogastroenterol Motil
.
2017
Oct
;
23
(
4
):
555
60
.
[PubMed]
2093-0879
10.
Koloski
NA
,
Jones
M
,
Talley
NJ
.
Evidence that independent gut-to-brain and brain-to-gut pathways operate in the irritable bowel syndrome and functional dyspepsia: a 1-year population-based prospective study
.
Aliment Pharmacol Ther
.
2016
Sep
;
44
(
6
):
592
600
.
[PubMed]
0269-2813
11.
Jones
MP
,
Tack
J
,
Van Oudenhove
L
,
Walker
MM
,
Holtmann
G
,
Koloski
NA
, et al.
Mood and Anxiety Disorders Precede Development of Functional Gastrointestinal Disorders in Patients but Not in the Population
.
Clin Gastroenterol Hepatol
.
2017
Jul
;
15
(
7
):
1014
1020.e4
.
[PubMed]
1542-3565
12.
Koloski
NA
,
Jones
M
,
Kalantar
J
,
Weltman
M
,
Zaguirre
J
,
Talley
NJ
.
The brain—gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study
.
Gut
.
2012
Sep
;
61
(
9
):
1284
90
.
[PubMed]
0017-5749
13.
Holtmann
GJ
,
Ford
AC
,
Talley
NJ
.
Pathophysiology of irritable bowel syndrome
.
Lancet Gastroenterol Hepatol
.
2016
Oct
;
1
(
2
):
133
46
.
[PubMed]
2468-1253
14.
Schwarz
E
,
Maukonen
J
,
Hyytiäinen
T
,
Kieseppä
T
,
Orešič
M
,
Sabunciyan
S
, et al.
Analysis of microbiota in first episode psychosis identifies preliminary associations with symptom severity and treatment response
.
Schizophr Res
.
2017
Apr
;
•••
:
1
6
.
[PubMed]
0920-9964
15.
Romijn
JA
,
Corssmit
EP
,
Havekes
LM
,
Pijl
H
.
Gut-brain axis
.
Curr Opin Clin Nutr Metab Care
.
2008
Jul
;
11
(
4
):
518
21
.
[PubMed]
1363-1950
16.
Carabotti
M
,
Scirocco
A
,
Maselli
MA
,
Severi
C
.
The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems
.
Ann Gastroenterol
.
2015
Apr-Jun
;
28
(
2
):
203
9
.
[PubMed]
1108-7471
17.
Cryan
JF
,
Dinan
TG
.
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
.
Nat Rev Neurosci
.
2012
Oct
;
13
(
10
):
701
12
.
[PubMed]
1471-003X
18.
Yoo
BB
,
Mazmanian
SK
.
The Enteric Network: Interactions between the Immune and Nervous Systems of the Gut
.
Immunity
.
2017
Jun
;
46
(
6
):
910
26
.
[PubMed]
1074-7613
19.
Hagbom
M
,
Istrate
C
,
Engblom
D
,
Karlsson
T
,
Rodriguez-Diaz
J
,
Buesa
J
, et al.
Rotavirus stimulates release of serotonin (5-HT) from human enterochromaffin cells and activates brain structures involved in nausea and vomiting
.
PLoS Pathog
.
2011
Jul
;
7
(
7
):
e1002115
10
.
[PubMed]
1553-7366
20.
Powell
N
,
Walker
MM
,
Talley
NJ
.
The mucosal immune system: master regulator of bidirectional gut-brain communications
.
Nat Rev Gastroenterol Hepatol
.
2017
Mar
;
14
(
3
):
143
59
.
[PubMed]
1759-5045
21.
Sominsky
L
,
Fuller
EA
,
Bondarenko
E
,
Ong
LK
,
Averell
L
,
Nalivaiko
E
, et al.
Functional programming of the autonomic nervous system by early life immune exposure: implications for anxiety
.
PLoS One
.
2013
;
8
(
3
):
e57700
13
.
[PubMed]
1932-6203
22.
Sominsky
L
,
Walker
AK
,
Ong
LK
,
Tynan
RJ
,
Walker
FR
,
Hodgson
DM
.
Increased microglial activation in the rat brain following neonatal exposure to a bacterial mimetic
.
Behav Brain Res
.
2012
Jan
;
226
(
1
):
351
6
.
[PubMed]
0166-4328
23.
Ong
LK
,
Fuller
EA
,
Sominsky
L
,
Hodgson
DM
,
Dunkley
PR
,
Dickson
PW
.
Early life peripheral lipopolysaccharide challenge reprograms catecholaminergic neurons
.
Sci Rep
.
2017
Jan
;
7
(
1
):
40475
.
[PubMed]
2045-2322
24.
Gordon
R
,
Spector
S
,
Sjoerdsma
A
,
Udenfriend
S
.
Increased synthesis of norepinephrine and epinephrine in the intact rat during exercise and exposure to cold
.
J Pharmacol Exp Ther
.
1966
Sep
;
153
(
3
):
440
7
.
[PubMed]
0022-3565
25.
Karrow
NA
.
Activation of the hypothalamic-pituitary-adrenal axis and autonomic nervous system during inflammation and altered programming of the neuroendocrine-immune axis during fetal and neonatal development: lessons learned from the model inflammagen, lipopolysaccharide
.
Brain Behav Immun
.
2006
Mar
;
20
(
2
):
144
58
.
[PubMed]
0889-1591
26.
Mayer
EA
,
Savidge
T
,
Shulman
RJ
.
Brain-gut microbiome interactions and functional bowel disorders
.
Gastroenterology
.
2014
May
;
146
(
6
):
1500
12
.
[PubMed]
0016-5085
27.
Foster
JA
,
McVey Neufeld
KA
.
Gut-brain axis: how the microbiome influences anxiety and depression
.
Trends Neurosci
.
2013
May
;
36
(
5
):
305
12
.
[PubMed]
0166-2236
28.
Lee
SH
.
Intestinal permeability regulation by tight junction: implication on inflammatory bowel diseases
.
Intest Res
.
2015
Jan
;
13
(
1
):
11
8
.
[PubMed]
1598-9100
29.
Peterson
LW
,
Artis
D
.
Intestinal epithelial cells: regulators of barrier function and immune homeostasis
.
Nat Rev Immunol
.
2014
Mar
;
14
(
3
):
141
53
.
[PubMed]
1474-1733
30.
Houser
MC
,
Tansey
MG
.
The gut-brain axis: is intestinal inflammation a silent driver of Parkinson’s disease pathogenesis? npj
.
Parkinsons Dis
.
2017
Jan
;
3
:
1
9
.2042-0080
31.
Di Filippo
M
,
Chiasserini
D
,
Gardoni
F
,
Viviani
B
,
Tozzi
A
,
Giampà
C
, et al.
Effects of central and peripheral inflammation on hippocampal synaptic plasticity
.
Neurobiol Dis
.
2013
Apr
;
52
:
229
36
.
[PubMed]
0969-9961
32.
Groschwitz
KR
,
Hogan
SP
.
Intestinal barrier function: molecular regulation and disease pathogenesis
.
J Allergy Clin Immunol
.
2009
Jul
;
124
(
1
):
3
20
.
[PubMed]
0091-6749
33.
Keita
ÅV
,
Söderholm
JD
.
The intestinal barrier and its regulation by neuroimmune factors
.
Neurogastroenterol Motil
.
2010
Jul
;
22
(
7
):
718
33
.
[PubMed]
1350-1925
34.
González-Mariscal
L
,
Betanzos
A
,
Nava
P
,
Jaramillo
BE
.
Tight junction proteins
.
Prog Biophys Mol Biol
.
2003
Jan
;
81
(
1
):
1
44
.
[PubMed]
0079-6107
35.
Förster
C
.
Tight junctions and the modulation of barrier function in disease
.
Histochem Cell Biol
.
2008
Jul
;
130
(
1
):
55
70
.
[PubMed]
0948-6143
36.
Boksa
P
.
Effects of prenatal infection on brain development and behavior: a review of findings from animal models
.
Brain Behav Immun
.
2010
Aug
;
24
(
6
):
881
97
.
[PubMed]
0889-1591
37.
Meehan
C
,
Harms
L
,
Frost
JD
,
Barreto
R
,
Todd
J
,
Schall
U
, et al.
Effects of immune activation during early or late gestation on schizophrenia-related behaviour in adult rat offspring
.
Brain Behav Immun
.
2017
Jul
;
63
:
8
20
.
[PubMed]
0889-1591
38.
Rahman
T
,
Zavitsanou
K
,
Purves-Tyson
T
,
Harms
LR
,
Meehan
C
,
Schall
U
, et al.
Effects of Immune Activation during Early or Late Gestation on N-Methyl-d-Aspartate Receptor Measures in Adult Rat Offspring
.
Front Psychiatry
.
2017
Sep
;
8
:
77
.
[PubMed]
1664-0640
39.
Duchatel
RJ
,
Jobling
P
,
Graham
BA
,
Harms
LR
,
Michie
PT
,
Hodgson
DM
, et al.
Increased white matter neuron density in a rat model of maternal immune activation - Implications for schizophrenia
.
Prog Neuropsychopharmacol Biol Psychiatry
.
2016
Feb
;
65
:
118
26
.
[PubMed]
0278-5846
40.
Sengupta
P
: The Laboratory Rat- Relating Its Age With Human's.pdf. International Journal of Preventative Medicine
2013
Jun;:624–630.
41.
Dickson
PW
,
Briggs
GD
. Chapter Two - Tyrosine Hydroxylase: Regulation by Feedback Inhibition and Phosphorylation. In:
Eiden
LE
, editor
.
A New Era of Catecholamines in the Laboratory and Clinic
.
Academic Press
;
2013
. pp.
13
21
.
42.
Livak
KJ
,
Schmittgen
TD
.
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Δ Δ C(T)) Method
.
Methods
.
2001
Dec
;
25
(
4
):
402
8
.
[PubMed]
1046-2023
43.
Vandesompele
J
,
De Preter
K
,
Pattyn
F
,
Poppe
B
,
Van Roy
N
,
De Paepe
A
, et al.
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes
.
Genome Biol
.
2002
Jun
;
3
(
7
):
H0034
.
[PubMed]
1474-7596
44.
Moolenbeek
C
,
Ruitenberg
EJ
.
The “Swiss roll”: a simple technique for histological studies of the rodent intestine
.
Lab Anim
.
1981
Jan
;
15
(
1
):
57
9
.
[PubMed]
0023-6772
45.
Lynn
DA
,
Brown
GR
.
The ontogeny of anxiety-like behavior in rats from adolescence to adulthood
.
Dev Psychobiol
.
2010
Dec
;
52
(
8
):
731
9
.
[PubMed]
0012-1630
46.
Balda
MS
,
Garrett
MD
,
Matter
K
.
The ZO-1-associated Y-box factor ZONAB regulates epithelial cell proliferation and cell density
.
J Cell Biol
.
2003
Feb
;
160
(
3
):
423
32
.
[PubMed]
0021-9525
47.
Balda
MS
,
Matter
K
:
Tight junctions and the regulation of gene expression.
BBA - Biomembranes 2009 Apr 1;
1788
:761–767.
48.
González-Mariscal
L
,
Miranda
J
,
Raya-Sandino
A
,
Domínguez-Calderón
A
,
Cuellar-Perez
F
.
ZO-2, a tight junction protein involved in gene expression, proliferation, apoptosis, and cell size regulation
.
Ann N Y Acad Sci
.
2017
Jun
;
1397
(
1
):
35
53
.
[PubMed]
0077-8923
49.
Barreau
F
,
Meinzer
U
,
Chareyre
F
,
Berrebi
D
,
Niwa-Kawakita
M
,
Dussaillant
M
, et al.
CARD15/NOD2 is required for Peyer’s patches homeostasis in mice
.
PLoS One
.
2007
Jun
;
2
(
6
):
e523
11
.
[PubMed]
1932-6203
50.
Rogers
GB
,
Keating
DJ
,
Young
RL
,
Wong
ML
,
Licinio
J
,
Wesselingh
S
.
From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways
.
Mol Psychiatry
.
2016
Jun
;
21
(
6
):
738
48
.
[PubMed]
1359-4184
51.
Edelblum
KL
,
Shen
L
,
Weber
CR
,
Marchiando
AM
,
Clay
BS
,
Wang
Y
, et al.
Dynamic migration of γδ intraepithelial lymphocytes requires occludin
.
Proc Natl Acad Sci USA
.
2012
May
;
109
(
18
):
7097
102
.
[PubMed]
0027-8424
52.
Chen
Y
,
Chou
K
,
Fuchs
E
,
Havran
WL
,
Boismenu
R
.
Protection of the intestinal mucosa by intraepithelial γ δ T cells
.
Proc Natl Acad Sci USA
.
2002
Oct
;
99
(
22
):
14338
43
.
[PubMed]
0027-8424
53.
Edelblum
KL
,
Singh
G
,
Odenwald
MA
,
Lingaraju
A
,
El Bissati
K
,
McLeod
R
, et al.
γδ Intraepithelial Lymphocyte Migration Limits Transepithelial Pathogen Invasion and Systemic Disease in Mice
.
Gastroenterology
.
2015
Jun
;
148
(
7
):
1417
26
.
[PubMed]
0016-5085
54.
Mansueto
P
,
Iacono
G
,
Seidita
A
,
D’Alcamo
A
,
Sprini
D
,
Carroccio
A
.
Review article: intestinal lymphoid nodular hyperplasia in children—the relationship to food hypersensitivity
.
Aliment Pharmacol Ther
.
2012
May
;
35
(
9
):
1000
9
.
[PubMed]
0269-2813
55.
Albuquerque
A
.
Nodular lymphoid hyperplasia in the gastrointestinal tract in adult patients: A review
.
World J Gastrointest Endosc
.
2014
Nov
;
6
(
11
):
534
40
.
[PubMed]
1948-5190
56.
Shah
N
,
Thakkar
B
,
Shen
E
,
Loh
M
,
Chong
PY
,
Gan
WH
, et al.
Lymphocytic follicles and aggregates are a determinant of mucosal damage and duration of diarrhea
.
Arch Pathol Lab Med
.
2013
Jan
;
137
(
1
):
83
9
.
[PubMed]
0003-9985
57.
Kronfol
Z
,
Remick
DG
.
Cytokines and the brain: implications for clinical psychiatry
.
Am J Psychiatry
.
2000
May
;
157
(
5
):
683
94
.
[PubMed]
0002-953X
58.
Keely
S
,
Walker
MM
,
Marks
E
,
Talley
NJ
.
Immune dysregulation in the functional gastrointestinal disorders
.
Eur J Clin Invest
.
2015
Dec
;
45
(
12
):
1350
9
.
[PubMed]
0014-2972
59.
Kuhn
KA
,
Manieri
NA
,
Liu
TC
,
Stappenbeck
TS
.
IL-6 stimulates intestinal epithelial proliferation and repair after injury
.
PLoS One
.
2014
Dec
;
9
(
12
):
e114195
18
.
[PubMed]
1932-6203
60.
Jeffery
V
,
Goldson
AJ
,
Dainty
JR
,
Chieppa
M
,
Sobolewski
A
.
IL-6 Signaling Regulates Small Intestinal Crypt Homeostasis
.
J Immunol
.
2017
Jul
;
199
(
1
):
304
11
.
[PubMed]
0022-1767
61.
Suzuki
T
,
Yoshinaga
N
,
Tanabe
S
.
Interleukin-6 (IL-6) regulates claudin-2 expression and tight junction permeability in intestinal epithelium
.
J Biol Chem
.
2011
Sep
;
286
(
36
):
31263
71
.
[PubMed]
0021-9258
62.
O’Malley
D
,
Dinan
TG
,
Cryan
JF
.
Interleukin-6 modulates colonic transepithelial ion transport in the stress-sensitive wistar kyoto rat
.
Front Pharmacol
.
2012
Nov
;
3
:
190
.
[PubMed]
1663-9812
63.
Peuhkuri
K
,
Vapaatalo
H
,
Korpela
R
.
Even low-grade inflammation impacts on small intestinal function
.
World J Gastroenterol
.
2010
Mar
;
16
(
9
):
1057
62
.
[PubMed]
1007-9327
64.
Mowat
AM
.
Anatomical basis of tolerance and immunity to intestinal antigens
.
Nat Rev Immunol
.
2003
Apr
;
3
(
4
):
331
41
.
[PubMed]
1474-1733
65.
Hodgson
DM
,
Coe
CL
.
Perinatal Programming: Early Life Determinants of Adult Health & Disease
.
London, New York
:
Taylor & Francis
;
2006
.
66.
Pohl
CS
,
Medland
JE
,
Moeser
AJ
.
Early-life stress origins of gastrointestinal disease: animal models, intestinal pathophysiology, and translational implications
.
Am J Physiol Gastrointest Liver Physiol
.
2015
Dec
;
309
(
12
):
G927
41
.
[PubMed]
0193-1857
67.
Villani
AC
,
Lemire
M
,
Fortin
G
,
Louis
E
,
Silverberg
MS
,
Collette
C
, et al.
Common variants in the NLRP3 region contribute to Crohn’s disease susceptibility
.
Nat Genet
.
2009
Jan
;
41
(
1
):
71
6
.
[PubMed]
1061-4036
68.
Zaki
MH
,
Boyd
KL
,
Vogel
P
,
Kastan
MB
,
Lamkanfi
M
,
Kanneganti
TD
.
The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis
.
Immunity
.
2010
Mar
;
32
(
3
):
379
91
.
[PubMed]
1074-7613
69.
Walf
AA
,
Frye
CA
.
The use of the elevated plus maze as an assay of anxiety-related behavior in rodents
.
Nat Protoc
.
2007
;
2
(
2
):
322
8
.
[PubMed]
1754-2189
70.
Meyer
U
,
Feldon
J
,
Schedlowski
M
,
Yee
BK
.
Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia
.
Neurosci Biobehav Rev
.
2005
;
29
(
6
):
913
47
.
[PubMed]
0149-7634
71.
Ratnayake
U
,
Quinn
TA
,
Castillo-Melendez
M
,
Dickinson
H
,
Walker
DW
.
Behaviour and hippocampus-specific changes in spiny mouse neonates after treatment of the mother with the viral-mimetic Poly I:C at mid-pregnancy
.
Brain Behav Immun
.
2012
Nov
;
26
(
8
):
1288
99
.
[PubMed]
0889-1591
72.
Yee
N
,
Ribic
A
,
de Roo
CC
,
Fuchs
E
.
Differential effects of maternal immune activation and juvenile stress on anxiety-like behaviour and physiology in adult rats: no evidence for the “double-hit hypothesis”
.
Behav Brain Res
.
2011
Oct
;
224
(
1
):
180
8
.
[PubMed]
0166-4328
73.
Meyer
U
,
Nyffeler
M
,
Engler
A
,
Urwyler
A
,
Schedlowski
M
,
Knuesel
I
, et al.
The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology
.
J Neurosci
.
2006
May
;
26
(
18
):
4752
62
.
[PubMed]
0270-6474
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.